Rosetta Genomics Ltd. (ROSG)’s LD MICRO “Main Event” Micro-Cap Growth Conference Transcript

Question: (inaudible)
Answer: No the miscellaneous code which is good news and bad news it doesn’t create a problem with medicare but it creates a problem with the commercial payers because when they give you the miscellaneous code they automatically take them out so it’s not house to house commercial payers.

Question: (inaudible)

You know, it’s one of the things where if it is not broke don’t fix it. The medicare thing is working for us right now it’s something we’ve looked at we’ve decided not going to touch it right now.

Question: (inaudible)
Answer: It’s just know that the local contractor that we deal with for medicare in Philadelphia just decided to go the miscellaneous code.

Question: (inaudible)
Answer: It is an azulnet platform where they custom make the chips on the recipe. So it’s a proprietary chip that has only our printed Micro RNAs so they are sent to the public but we have our own proprietary that are on that chip.

Question: (inaudible)
Answer: Don’t know I think there were some investors that came in on heavy probably in that time period but there was no specific event it would have triggered us actually the big event happened in January where we announced our first collaboration just at the beginning JP Morgan stock was up 40% and traded about 2 million shares but there was no particular event that it was released on the mag.

Alright, we are out. Thanks everybody.